XML 37 R26.htm IDEA: XBRL DOCUMENT

Summary of significant accounting policies (Tables)

9 Months Ended

Jun. 30, 2023

Summary of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of the Company’s cash and cash equivalents and non-current portion of restricted cash reported within the unaudited condensed consolidated balance sheets that sum to the total cash, cash equivalents and restricted cash shown in the Company’s condensed consolidated statements of cash flows:


(in thousands)	June 30, 2023		September 30, 2022
Cash and cash equivalents	$	307,459	$	378,687
Restricted cash, non-current	4,379		1,572
Total cash, cash equivalents and restricted cash	$	311,838	$	380,259

Schedule of Cash and Cash Equivalents


(in thousands)	June 30, 2023		September 30, 2022
Cash and cash equivalents	$	307,459	$	378,687
Restricted cash, non-current	4,379		1,572
Total cash, cash equivalents and restricted cash	$	311,838	$	380,259

The following table sets forth the cash and cash equivalents, short-term and equity investments as of June 30, 2023:


(in thousands)	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value
Cash and cash equivalents	$	307,459	$	—	$	—	$	307,459
Short-term investments:
Corporate bonds	26,133		5		(68)		26,070
U.S. government treasury bills	23,721		1		(106)		23,616
Equity investments	$	3,711	$	—	$	—	$	3,711
Total	$	361,024	$	6	$	(174)	$	360,856

The following table sets forth the cash and cash equivalents, and short-term investments as of September 30, 2022:


(in thousands)	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value
Cash and cash equivalents	$	378,687	$	—	$	—	$	378,687
Short-term investments:
Commercial paper	14,997		—		—		14,997
U.S. government treasury bills	112,878		—		(1,594)		111,284
Total	$	506,562	$	—	$	(1,594)	$	504,968